TORONTO, ONTARIO — (Marketwired) — 10/31/14 — The common shares of BioMark Diagnostics Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at .
If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: .
Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340